C ognate recognition of APC by antigen-specific T cells is critically dependent on adhesive interactions mediated by LFA1 molecules present on both T cells and APC (1) . While LFA-1 is constitutively expressed on lymphocytes, its adhesion function is activated after antigen-specific recognition (2) . Engagement of the TCR by mAbs was recently shown to upregulate the affinity of LFA-1 for its counter receptors (3, 4) . This proceeds via intracellular signaling mechanisms that involve the activation of protein kinase C (PKC). 
transformed lymphoblastoid B cell lines were derived from normal donors and from an immunodeficient patient with absent Ia expression . Monocytes were prepared as described (6) .
Aggregation Assays. Cells were resuspended in RPMI 1640 and seeded in 96-well microtiter plates at 2 x 101 cells/well for B cells, monocytes, and T cells, and at 5 x 104 for lymphoblastoid B cell lines. Cells were stimulated at 37°C for the indicated time periods with TSST-1 at 1 Fig/ml ; SEB at 10 Rg/ml; Fab mAb L243 at 1 t~g/ml ; Fab mAb ST2-59 at 1 hg/ml, or with PMA at 25 ug/ml. Cell aggregation was monitored using light microscopy by counting the number of cell aggregates containing 310 cells per well (7) . Values are means of scores of two wells ± SD, and the data are representative of three other experiments .
Results and Discussion recognizes an epitope on HLA-DR closely related to the TSST-1 binding site (8) . Aggregation induced by TSST 1 and by mAb L243 was similar in magnitude to that induced by the PKC activator PMA, which affects sustained activation of LFA-1 adhesion function (3, 9) . Two ligands that bind to epitopes distinct from those recognized by TSST-1 and by mAb L243, namely SEB and the Fab fragment of the anti-HLADR/DQ mAb ST2-59 (8, 10) , failed to induce B cell aggregation . Thus, induction of adhesion via Ia is restricted by the epitope specificity of the binding ligands .
TSST1 and mAb L243 induced the aggregation of other Ia' leukocytes, including activated T cells, monocytes, and B lymphoblastoid lines . The requirement for la surface expression for the induction of cell aggregation by TSST1 and mAb L243 was demonstrated by the failure of both ligands to induce the aggregation of resting T cells, which do not 151 4 Ligand Binding to la Activates express la molecules on their surface, or of B lymphoblastoid cells derived from a patient with congenital absence of Ia expression (11) (Fig. 1 C) . Adhesion induced by Ia-binding ligands was mediated by LFA 1 and its counter receptors. mAbs to either the a chain or the 0 chain of the LFA-1 heterodimer inhibited cell aggregation induced by TSST1 or by mAbs L243 (Fig. 2 A) , as well as by PMA, as previously noted (9) . In addition, a mAb directed against intercellular adhesion molecule 1(ICAM-1), a counter receptor for LFA1(12), partially inhibited cell aggregation induced by TSST1 and by mAb L243 (Fig . 2 A) . The more effective inhibition of cell aggregation by anti-LFA-1 mAbs compared with anti-ICAM-1 mAb suggests that other LFA1 counter receptors, such as ICAM-2 (13), play a role in la-triggered adhesion . la-mediated adhesion was less Lymphocyte Function-associated Molecule 1 Figure 3 . Ia ligands induce cell aggregation by activating the adhesion function of LFA-1 and not that of its counter receptors . T cell lines derived from a normal donor [NL] , from a leukocyte adhesion deficiency patient [LFA-1(-)], or from an la-deficient patient [Ia(-)] were propagated with PHA, IIT2, and irradiated allogeneic feeder cells as described (17) . All three lines expressed comparable levels of ICAM-1 and, when applicable, comparable levels of LFA-1 and Ia . Homogenous cell populations were seeded at 2 x 105 cells/well, while mixtures of two cell populations were seeded at 105 cells/well for each cell type, and the cells were treated with respective stimulus for 6 h. To ascertain heterotypic cell adhesion in mixture of different T cell populations, cells from population were first loaded with the dye 6 carboxyfluorescein diacetate at 100 juM for 1 h at 37°C, washed extensively, and then mixed with the respective cell type, stimulated for 6 h, and then examined by light and fluorescence microscopy. Similar results were obtained in one other experiment . amenable to disruption by mAbs to LFA1 and ICAM-1 as compared with PMAinduced adhesion. This may relate to a higher affinity interaction between LFA-1 and ICAM in cells activated via Ia or due to the involvement of other adhesion molecules in Ia-mediated adhesion. The critical role of LFA 1 in mediating adhesion induced by Ia-binding ligands was ascertained by studying a patient whose leukocytes were severely defective in the expression of LFA 1(<2% of normal) (14) . Fig . 2 B demonstrates that TSST 1 and mAb L243 induced adhesion in normal but not in LFA1-deficient PBMC preparations enriched in B lymphocytes and in monocytes. Finally, this cell aggregation was Mgt+ and temperature dependent, typical of LFA 1-mediated adhesion interactions (9) (data not shown) . Adhesion induced by Ia-binding ligands was not associated with upregulation of the surface expression of LFA 1 or of ICAM-1, and did not require protein synthesis, as it was not affected by cycloheximide, an inhibitor of protein synthesis (data not shown) . These results suggested that Ia-induced adhesion is effected by a qualitative change in LFA1 and/or its counter receptors .
Heterolytic adhesion experiments using primary T cell lines derived from normal donors, from the LFA 1-deficient patient, and from the Ia-deficient patient demonstrated that Iainduced adhesion was affected by activating LFA1 adhesion function and not by activating the adhesion function of LFA1 counter receptors. Fig . 3 A demonstrates that mAb L243 failed to elicit either homotypic or heterolytic aggregates in mixtures of LFA-1-deficient and Ia-deficient activated T cells. In contrast, PMA induced vigorous heterotypic aggregation in the same cell mixtures (Fig. 3 B) . Both mAb L243 and PMA induced heterolytic aggregation in mixtures of Ia+ T cells and LFA1-deficient cells, and in mixtures of Ia+ T cells and Ia-deficient T cells (Fig. 3) .
PKC activators may enhance LFA-1 function by inducing the phosphorylation of LFA1 (3 chain (6) or of cytoskeletal proteins that interact with LFA1, such as talin (15). To determine the role of PKC in Ia-mediated adhesion, we examined the capacity of the PKC inhibitor sphingosine (16) to antagonize the induction of adhesion by Ia-binding ligands . Fig. 4 A demonstrates that sphingosine inhibited the aggregation of tonsillar B cells induced by TSST 1, by mAb L243, or by PMA . In contrast, the inert sphingosine metabolite ceramide exhibited no effect on cell aggregation . Other protein kinase inhibitors such as stauroporine and H7 also inhibited cell aggregation (data not shown) . These results suggested that an Ia-coupled protein kinase, either PKC itself or a closely related enzyme, mediates the induction of adhe-
